Bronco Forum - Full Size Ford Bronco Forum banner

621 - 640 of 651 Posts

·
Premium Member
Joined
·
471 Posts

·
Registered
82 XLT Lariat 351w, Edelbrock 1406 4bbl ,C6 auto, auto locking hubs ,33x10.5x15
Joined
·
2,191 Posts
We're seeing that all over the place Frank... This so called "second wave" they're claiming is/could be worse then the first... Is because everyone's been isolated since the beginning of March and their immune system's down from not having the daily exposure to everyday pathogens.
The only other times I could find anything in American history that we responded this way with stay in and shut down orders were Spanish flu and an outbreak of small pox in like the late 1800s (I believe). Other then that we've always quarantined the sick and life went on as usual for the healthy regardless if they could have possibly been asymptomatic carriers... 😏
 

·
Registered
Joined
·
1,006 Posts
God bless Georgia

I'm more worried about our great state just giving away drivers licenses to 16 year old (without any driving tests) than contracting the Rona...….. I'm a white guy so jogging isn't an issue.



12 editorial and topical cartoons from the past week - May 12
 

·
Premium Member
Joined
·
471 Posts
Disney Springs here in FL reopens today. DS is an outdoor retail store area on the Disney property with several very cool restaurants geared for kids. LEGO store etc. They are requiring all patrons 3 and up to wear a face mask except when eating. I have to laugh thinking about parents trying to keep a face mask on a 3 year old especially when we start hitting temps here in the 90s with 100% humidity. Looks like I won’t be taking the grandkids to Disney anytime soon until they reverse this policy. Ah, the Disney experience parents fighting with their screaming kids to keep on their facemask in the boiling heat. I can see it now.
 

·
Registered
Joined
·
803 Posts
Berenson is definitely not a fan of continued lockdowns...




Sent from my iPhone using Tapatalk
 

·
Registered
Joined
·
9,550 Posts
Berenson is definitely not a fan of continued lockdowns...




Sent from my iPhone using Tapatalk
For anyone wondering who the **** Alex Berenson is.

Harbor freight has low stock of, well, everything. Couldn't get my 3500lb winch. From what I'm told the trucks are showing up with hardly any stock.
 

·
Registered
Joined
·
197 Posts
Wrong again wonder boy. Quote where I stated I know more than a world renowned PhD immunologist? However I do admit that a close friend is a world famed clinical and research immunologist.

Dr. Cahill’s CV and credentials suggest her opinion about ending the lockdown carries significantly more weight than your dribble that she is incorrect.

BIO
Prof. Dr Dolores Cahill is a world-wide renowned expert in high-throughput proteomics technology development and automation, high content protein arrays and their biomedical applications, including in biomarker discovery and diagnostics. Prof. Cahill pioneered this research area at the Max-Planck-Institute of Molecular Genetics in Berlin, Germany, and holds several international patents in this field with research, biomedicine and diagnostic applications. o Over 20 years expertise in high-throughput protein & antibody array, automation, proteomics technology development & biomedical applications in biomarker discovery, diagnostics & personalised medicine. o Since 2005 to present, Full Professor of Translational Science, School of Medicine, University College Dublin, Academic, Researcher, Lecturer, Module Coordinator in Pathology Teaching, School of Medicine & Conway Institute o 15 years as Irish, EU & international expert & advisor including Seconded National Expert to European Commission o Company Co-founder & Shareholder (1997-2019) of Protagen AG in Germany (https://protagen.com/). Protagen Protein Services (2012-2019) contract services to healthcare sector & pharmaceutical industry (Home | Protagen). o Since 2016, co-founding shareholder and Advisory Board member of Prof. Stephen Pennington’s UCD School of Medicine/Conway Institute spin-out company, Atturos Ltd. working to improve Prostate Cancer diagnosis (Home - Atturos and Advisory Board - Atturos). o Prof. Cahill has a total of over 5940 Citations, H (Hirsh)-index of 35, i10-index of 48. o Project management: Has successfully obtained and project managed as Principal Investigator eight EU Programme funding grants from FP4, FP5, FP6, FP7 and Horizon 2020, Science Foundation Ireland, Enterprise Ireland, Health Research Board funding in companies and universities. Selected Academic Leadership and Contributions: Member of Committees and Awards: o Vice Chair, European Union Innovative Medicines Initiative Scientific Committee (2018-2021) and Member, European Union Innovative Medicines Initiative Scientific Committee (2016-2021) and Vice-Chair (2018-2021) (https://www.imi.europa.eu/sites/default/files/uploads/documents/About-IMI/Governance/sc/IMI_SC_Bio_Dolores_Cahill.pdf). o In 2013-2014, worked in European Commission, Brussels seconded full-time, as a Seconded National Expert (SNE) to the European Commission Research & Innovation (HORIZON2020) (DG RTD) Directorate, in a Strategy and Policy Development role for International R&D&I Cooperation between the EU & Asia (S. Korea, China, ASEAN) & for the Coordination of Health Research, Development and Innovation globally. o In 2005, appointed by the Irish Prime Minister (Taoiseach) & Minister for Health as an Irish Government’s Advisory Science Council (ASC) Member (www.sciencecouncil.ie) (2005-2013) & to develop Irish Strategy for Science, Technology & Innovation (2006-2013) with Universities, Industry & Health, Education, Enterprise & Finance Depts. o Chaired the ASC Task Force ‘Towards a Framework for Researcher Careers’ & ASC Task Force member Report on ‘Promoting Enterprise-Higher Education Relationships’ (2009) and ‘Sustainability of Research Centres’ (2012) o Honoured with a lifetime award from the Federation of European Biochemical Societies Award in Norway (2009) for her research & its significance. Other awardees: Prof. J. Craig Venter & Nobel Prize winner, Prof. Robert Huber. o Awarded the prestigious BMBF BioFuture Prize by German Minister of Science (€1.5million) (2000). o Supervisor of over 20 completed PhD & Masters’ degrees in total. Chair of ten UCD PhD committees. Project management, Research and Peer-Reviewed Publications: o Prof. Cahill has a Hirsch h-index 35: i10-index 48. o Citations 5946 Google Scholar Citations: Google Scholar Selected Academic Leadership and Contributions: Invited Speaker, Keynotes, Conferences organised: o Prof. Cahill has given over 100 Keynotes in USA, Europe, China, Japan, S. Korea, Australia, South America: - 18th-19th May 2020: Chair, Global Bioprocessing, Bioanalytics & ATMP Manufacturing, Dublin. - 18th-19th June 2020: Keynote Speaker, BioTech Pharma Summit, CBB 2020, Portugal. - 24th-25th Sept 2020: Guest Speaker, Biotechnology Business Workshop, British Embassy & Biotech Atelier Sofia. - 8th-9th October 2020: Keynote Speaker, Global Engage, Liquid Biopsies Conference, London. - 13th-14th February 2019: Keynote Speaker Companion Diagnostics & Biomarkers Conference 2019 - 13th-15th March 2019: Speaker, Intergovernmental meeting in Bulgaria - 10th -11th October 2019: Chair and Speaker, Immuno-oncology, London (Liquid Biopsies Congress 2019) - 13th-14th September 2018: Speaker, 5th Precision Medicine & Biomarkers Leaders’ Summit, Munich & Chair of Roundtable on Personalised Medicine & Adverse Events (http://www.giiconference.com/gel560004/catalog.pdf?1528437050). o 9th March 2020: Prof. Cahill invited to speak on the panel ‘A View from the Top: UCD Medicine Female Professors in Conversation’ to mark International Women's Day 2020 (What's On) o 17th-21st September 2017: HUPO2017: Human Proteome Organising (HUPO) Committee Member. The Annual HUPO World meeting was held in Dublin. UCD Prof. Stephen Pennington was Conference Chair. Prof. Cahill was HUPO 2017 Chief Financial Officer (Prof. Dr Dolores Cahill | HUPO 2017) & had over 1300 attendees with 90% from outside Ireland. Total budget € 1,300,000 & small profit made was returned to the sponsor, British Proteome Society. USA Vice-President (News | HUPO 2017) launched Global Cancer Moonshot at Conference Gala dinner. Selected Peer Reviewed Publications: · Medical Errors & Adverse Events: leading cause of death and disease burden. Cahill, Dolores (2018) Health Europa: 7:42-43. (http://edition.pagesuite-professional.co.uk/html5/reader/production/default.aspx?pubname=&edid=73e202a8-1e25-4d2e-afc3-1cd95c26e5ae) ·Anti-ribosomal-phosphoprotein autoantibodies penetrate to neuronal cells via neuronal growth associated protein (GAP43), affecting neuronal cells in-vitro. Kivity, Shaye; Shoenfeld, Yehuda; Arango, Maria Terresa; Cahill, Dolores J; O'Kane, Sara Louise; Zusev, Margalit; Slutsky, Inna; Harel-Meir, Michal; Chapman, Joab; Mathias, Torsten; Blank, Miri. (2017) Rheumatology RHE-15-1025. · Ligand-directed targeting of lymphatic vessels uncovers mechanistic insights in melanoma metastasis D. R. Christiansona, A. S. Dobroffb, B. Pronetha,A. J. Zuritad, A. Salameha, et al., D. J. Cahill, J. E. Gershenwaldg, R. L. Sidmanj, Wadih Arap, R. Pasqualini (2015) Proceedings of the National Academy of Sciences PNAS USA 2015 Feb 6. pii: 201424994. PMID: 25659743 www.pnas.org/cgi/doi/10.1073/pnas.1424994112. · Highly sensitive toxin microarray assay to improve Aflatoxin B1 detection in food. Beizaei A, O’ Kane SL, Kamkar A, Misaghi A, Henehan G, Cahill DJ. (2015) Food Chemistry Vol 57: 210–215 DOI:10.1016/j.foodcont.2015.03.039. ·The Functional Bionano Interface–Mapping the Interactions at the Interface Between the Hard and Soft Protein Corona. O’Connell DJ, Baldelli Bombelli F, Cahill DJ and Dawson KA. (2014) Nanoscale: Sept 1: DOI: 10.1039/c5nr01970b ·Epitope presentation is an important determinant of the utility of antigens identified from protein arrays in the development of autoantibody diagnostic assays. Murphy MA, O'Connell DJ, O'Kane SL, O'Brien JK, O'Toole S, Martin C, Sheils O, O'Leary JJ, Cahill DJ. Journal Proteomics. (2013) 75(15):4668-75. PMID: 22415278. · Vascular ligand-receptor mapping by direct combinatorial selection in cancer patients. Staquicini FI, Cardó-Vila M, Kolonin MG, Trepel M, Edwards JK, Nunes DN, Sergeeva A, Efstathiou E, Sun J, Almeida NF, Tu SM, Botz GH, Wallace MJ, O'Connell DJ, Krajewski S, Gershenwald JE, Molldrem JJ, Flamm AL, Koivunen E, Pentz RD, Dias-Neto E, Setubal JC, Cahill DJ, Troncoso P, Do KA, Logothetis CJ, Sidman RL, Pasqualini R, Arap W. Proc Natl Acad Sci U S A. (2012) 108(46):18637-42. PMID: 22049339. ·Assessment of the humoral immune response to cancer. Murphy MA, O'Leary JJ, Cahill DJ. Journal Proteomics. (2012) 3;75(15):4573-9. PMID: 22300580. · Proteomic analysis & discovery using affinity proteomics and mass spectrometry. Olsson N, Wingren C, Mattsson M, James P, O'Connell D, Nilsson F, Cahill DJ, Borrebaeck CA. Mol Cell Proteomics. (2011) 10(10):M110.003962. PMID: 21673276. · Optimized autoantibody profiling on protein arrays. O'Kane SL, O'Brien JK, Cahill DJ. Methods Mol Biol. (2011) 785:331-41. PMID: 21901610. · Probing calmodulin protein-protein interactions using high-content protein arrays. O'Connell DJ, Bauer M, Linse S, Cahill DJ. Methods Mol Biol. (2011) 785:289-303. PMID: 21901608. · Protein networks involved in vesicle fusion, transport, and storage revealed by array-based proteomics. Bauer M, Maj M, Wagner L, Cahill DJ, Linse S, O'Connell DJ. Methods Mol Biol. (2011) 781:47-58. PMID: 21877276. · Identification of a high-affinity network of secretagogin-binding proteins involved in vesicle secretion. Bauer MC, O'Connell DJ, Maj M, Wagner L, Cahill DJ, Linse S. Mol Biosyst. (2011) Jul;7(7):2196-204. PMID: 21528130 · Drug profiling: knowing where it hits. Merino A, Bronowska AK, Jackson DB, Cahill DJ. Drug Discovery Today. (2010) Sep;15(17-18):749-56. Epub 2010 Jun 18. PMID: 20601095. ·Integrated protein array screening and high throughput validation of 70 novel neural calmodulin-binding proteins. O'Connell DJ, Bauer MC, O'Brien J, Johnson WM, Divizio CA, O'Kane SL, Berggård T, Merino A, Akerfeldt KS, Linse S, Cahill DJ. Mol Cell Proteomics. (2010) Jun;9(6):1118-32. Epub 2010 Jan 12. PMID: 20068228. ·Diagnostic and prognostic biomarker discovery strategies for autoimmune disorders. Gibson DS, Banha J, Penque D, Costa L, Conrads TP, Cahill DJ, O'Brien JK, Rooney ME. Journal Proteomics. (2010) Apr 18;73(6):1045-60. Epub 2009 Dec 5. Review. PMID: 19995622. · Calmodulin binding to the polybasic C-termini of STIM proteins involved in store-operated calcium entry. Bauer MC, O'Connell D, Cahill DJ, Linse S. Biochemistry. (2008) Jun 10;47(23):6089-91. PMID: 18484746. ·ProteomeBinders: planning a European resource of affinity reagents for analysis of the human proteome. Taussig MJ, Stoevesandt O, Borrebaeck CA, Bradbury AR, Cahill D, et al., Skerra A, Templin M, Ueffing M, Uhlén M. Nature Methods. (2007) Jan;4(1):13-7. PMID: 17195019. · Profiling humoral autoimmune repertoire of dilated cardiomyopathy (DCM) patients and development of a disease-associated protein chip. Horn S, Lueking A, Murphy D, Staudt A, Gutjahr C, Schulte K, König A, Landsberger M, Lehrach H, Felix SB, Cahill DJ. Proteomics. (2006) Jan;6(2):605-13. PMID: 16419013. · High throughput identification of potential Arabidopsis mitogen-activated protein kinases substrates. Feilner T, Hultschig C, Lee J, Meyer S, Immink RG, Koenig A, Possling A, Seitz H, Beveridge A, Scheel D, Cahill DJ, Lehrach H, Kreutzberger J, Kersten B. Mol Cell Proteomics. (2005) Oct;4(10):1558-68. Epub 2005 Jul 11. PMID: 16009969. · Profiling of alopecia areata autoantigens based on protein microarray technology. Lueking A, Huber O, Wirths C, Schulte K, Stieler KM, Blume-Peytavi U, Kowald A, Hensel-Wiegel K, Tauber R, Lehrach H, Meyer HE, Cahill DJ. Mol Cell Proteomics. (2005) Sep;4(9):1382-90. Epub 2005 Jun 6. PMID: 15939964. · Protein biochips: A new & versatile platform technology for molecular medicine. Lueking A, Cahill DJ, Müllner S. Drug Discov Today. (2005) Jun 1;10(11):789-94. Review. PMID: 15922937. · Bacterial protein microarrays for identification of new potential diagnostic markers for Neisseria meningitidis infections. Steller S, Angenendt P, Cahill DJ, Heuberger S, Lehrach H, Kreutzberger Journal Proteomics (2005)5(8):2048-55. PMID:15852346. · ICln, a novel integrin alphaIIbbeta3-associated protein, functionally regulates platelet activation. Larkin D, Murphy D, Reilly DF, Cahill M, Sattler E, Harriott P, Cahill DJ, Moran N. J Biological Chemistry (2004) Jun 25;279(26):27286-93. PMID: 15075326. · Cell-free protein expression and functional assay in nanowell chip format. Angenendt P, Nyarsik L, Szaflarski W, Glökler J, Nierhaus KH, Lehrach H, Cahill DJ, Lueking A. Analytical Chemistry (2004) Apr 1;76(7):1844-9. PMID: 15053642. · 3D protein microarrays: performing multiplex immunoassays on a single chip. Angenendt P, Glökler J, Konthur Z, Lehrach H, Cahill DJ. Analytical Chemistry (2003) Sep 1;75(17):4368-72. PMID: 14632038. · Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Coppinger JA, Cagney G, Toomey S, Kislinger T, Belton O, McRedmond JP, Cahill DJ, Emili A, Fitzgerald DJ, Maguire PB. Blood. (2004) Mar 15;103(6):2096-104. Epub 2003 Nov 20. PMID: 14630798. · A nonredundant human protein chip for antibody screening and serum profiling. Lueking A, Possling A, Huber O, Beveridge A, Horn M, Eickhoff H, Schuchardt J, Lehrach H, Cahill DJ. Mol Cell Proteomics. (2003) Dec;2(12):1342-9. PMID: 14517340. · Next generation of protein microarray support materials: evaluation for protein and antibody microarray applications. Angenendt P, Glökler J, Sobek J, Lehrach H, Cahill DJ. J Chromatography A. (2003) 15;1009(1-2):97-104. PMID: 13677649. · A dual-expression vector allowing expression in E. coli and P. pastoris, including new modifications. Lueking A, Horn S, Lehrach H, Cahill DJ. Methods Molecular Biology (2003) 205:31-42. PMID: 12491878. · Toward optimized antibody microarrays: a comparison of current microarray support materials. Angenendt P, Glökler J, Murphy D, Lehrach H, Cahill DJ. Analytical Biochemistry (2002) Oct 15;309(2):253-60. PMID: 12413459. · Generation of minimal protein identifiers of proteins from two-dimensional gels & recombinant proteins. Schmidt F, Lueking A, Nordhoff E, Gobom J, Klose J, Seitz H, Egelhofer V, Eickhoff H, Lehrach H, Cahill DJ. Electrophoresis (2002) Feb;23(4):621-5. PMID:11870774. · Steps toward mapping the human vasculature by phage display. Arap W, Kolonin MG, Trepel M, et al., Cahill D, Troncoso P et al., Do KA, Logothetis CJ, Pasqualini R. Nature Medicine (2002) Feb;8(2):121-7. PMID: 11821895.
UNIVERSITY COLLEGE DUBLIN APPOINTMENTS
  • Full Professor
    University College Dublin, School of Medicine, Dublin 4, Ireland1 Oct 2010
DEGREES
  • BA
    Trinity College Dublin
  • PhD
    Dublin City University (DCU) IRL
But nothing you have here has any bearing on what I posted.
I didn't see where you pointed out that the lady is running political campaigns to remove the officials she is talking about from office. She is a politician, and should be treated as such.

Claiming Euthanasia is simply a political ploy, and claiming a lifetime immunity from the virus is simply unscientific, and your listing of her accomplishments only make those claims worse.

I must have misinterpreted your comments about the use of hydroxychloroquine in the treatment of COVID0-19. You do support the statement that the drug should only be used in hospitals, and clinical trials?

And again, name calling only indicates sloppy research, not any knowledge.
 

·
Premium Member
Joined
·
471 Posts
But nothing you have here has any bearing on what I posted.
I didn't see where you pointed out that the lady is running political campaigns to remove the officials she is talking about from office. She is a politician, and should be treated as such.

Claiming Euthanasia is simply a political ploy, and claiming a lifetime immunity from the virus is simply unscientific, and your listing of her accomplishments only make those claims worse.

I must have misinterpreted your comments about the use of hydroxychloroquine in the treatment of COVID0-19. You do support the statement that the drug should only be used in hospitals, and clinical trials?

And again, name calling only indicates sloppy research, not any knowledge.
There could be lifetime immunity from Covid19 if people generate IgG antibodies, kinda like chickenpox, smallpox, polio, etc., so her statement about lifetime immunity is not out of bounds. We know patients are testing for the presence of IgG antibodies to Covid at the present time so some of those patients could have lasting immunity. ‘Still, some experts—including the foremost COVID-19 resource in the US, Dr. Anthony Fauci, the government's top infectious disease specialist—feel confident that those exposed to and infected by the coronavirus will develop some immunity. "If this virus acts like every other virus that we know, once you get infected, get better, clear the virus, then you’ll have immunity that will protect you against re-infection,” Dr. Fauci said in a recent interview on The Daily Show.’

I do not support the statement that the drug should only be used in hospitals and clinical trials. Practitioners have the right to use medications proven safe, off label if in their clinical judgement it will benefit a patient. It’s done everyday in medicine where medications are routinely used off label. You know that right?

Another example is the practice of poly-pharmacy where multiple medications are utilized in the same patient. There are no scientific studies to support the use of poly-pharmacy because the studies would be impossible to perform given the many different combinations of drugs combined on a daily basis in different patients. You know that right? However based on a clinicians expertise and clinical experience the practice occurs daily with patients despite lack of scientific evidence. The evidence comes from a practitioners experience that ‘xyz’ combinations of meds has shown helpful and safe in their patients. Experience in clinical application is key. I forgot to add, goodnight goofball.
 

·
Registered
82 XLT Lariat 351w, Edelbrock 1406 4bbl ,C6 auto, auto locking hubs ,33x10.5x15
Joined
·
2,191 Posts
Lol my hubby had chicken pox twice even tho he was vaccinated...
I thought I was harder for the body to develop natural immunity to an RNA based virus... the flu and covid 19 are RNA viruses and these mutate. Unlike measles mumps etc which are DNA types and are stable for decades.
 

·
Premium Member
Joined
·
471 Posts
Lol my hubby had chicken pox twice even tho he was vaccinated...
I thought I was harder for the body to develop natural immunity to an RNA based virus... the flu and covid 19 are RNA viruses and these mutate. Unlike measles mumps etc which are DNA types and are stable for decades.
Yep, you’re correct these rna viruses can trick and evade the immune system one reason making anti-virals and vaccines for them is difficult. Active immunity whether thru natural infection or vaccination essentially works the same way. The difficulty is going to be developing a vaccine quickly that’s safe. Remember swine flu shots? People naturally exposed to this bug who recovered are evidently making useful antibodies which are being used for passive immunity. Spinning down their blood to get the plasma so their convalescent antibodies can be injected into ill people Is being used more as time goes on. Passive immunity may be the way to go for now as it’s going to take time for a safe vaccine to come to fruition, but we’ll see.
 

·
Registered
Joined
·
1,006 Posts
Coming from the cold storage food service distribution industry for 20 years I have a ton of experience in HACCP. Hazardous analysis of critical control points. You have to look at your entire supply chain to find any chance that the product might get contaminated or temperature compromised... and put a plan in place to reduce the risk as much as possible. As an example the receiving dock is a critical control point. After unloading from the semi trailer the product is on the clock to be received and moved into the freezer. In order to reduce the risk of the temperature becoming compromised on the dock every pallet should be time stamped and monitored to ensure proper handling and time management.

Now our everyday day lives should be evaluated for critical control points and a HACCP plan should be in place to ensure our health is not compromised. Every place that you are exposed to the public should be considered a Critical control point, and a plan should be in place to reduce the risk of infection as much as possible. This includes proper PPE and procedures to reduce the risk of infection. ie. every time you use a gas pump you wipe the handle before use.

As stated above we are not even close to the total number of deaths associated with this virus. Everyone needs to be alert and have a HACCP plan that makes sense related to their risk of exposure.

Some of us are young and risk is minimal. My analogy would be that we are moving frozen bagels through a supply chain. Cost of the product is not high, and risk of contamination is low... since a thawed out bagel will probably not kill you. However a HACCP plan must be in place to ensure the proper handling of the product...no one likes a stale/moldy bagel

Some of us are at risk. My analogy would be we are moving fresh processed chicken into a blast freezer. Extra care an attention MUST be maintained at every critical control point. Time stamps and movement data are essential to ensure the product does not become contaminated and result in possible death. I'm not saying that any warehouse should ever be dirty... but that chicken processing warehouse needs to be cleaned at a higher rate than the bagel one.

If you have not changed anything in your daily routine..... you have no HACCP plan in place...… and are part of the problem and not part of the solution.
 

·
--------------
Joined
·
4,356 Posts
Discussion Starter #633

·
Registered
Joined
·
197 Posts
There could be lifetime immunity from Covid19 if people generate IgG antibodies, kinda like chickenpox, smallpox, polio, etc., so her statement about lifetime immunity is not out of bounds. We know patients are testing for the presence of IgG antibodies to Covid at the present time so some of those patients could have lasting immunity. ‘Still, some experts—including the foremost COVID-19 resource in the US, Dr. Anthony Fauci, the government's top infectious disease specialist—feel confident that those exposed to and infected by the coronavirus will develop some immunity. "If this virus acts like every other virus that we know, once you get infected, get better, clear the virus, then you’ll have immunity that will protect you against re-infection,” Dr. Fauci said in a recent interview on The Daily Show.’

I do not support the statement that the drug should only be used in hospitals and clinical trials. Practitioners have the right to use medications proven safe, off label if in their clinical judgement it will benefit a patient. It’s done everyday in medicine where medications are routinely used off label. You know that right?

Another example is the practice of poly-pharmacy where multiple medications are utilized in the same patient. There are no scientific studies to support the use of poly-pharmacy because the studies would be impossible to perform given the many different combinations of drugs combined on a daily basis in different patients. You know that right? However based on a clinicians expertise and clinical experience the practice occurs daily with patients despite lack of scientific evidence. The evidence comes from a practitioners experience that ‘xyz’ combinations of meds has shown helpful and safe in their patients. Experience in clinical application is key. I forgot to add, goodnight goofball.
"There could be lifetime immunity from Covid19 if people generate IgG antibodies, kinda like chickenpox, smallpox, polio, etc., so her statement about lifetime immunity is not out of bounds." Isn't it amazing how much difference one word can make? Could: used to indicate possibility. Unfortunately she didn't use the word could, which made her statement seriously out of bounds.

Oh, yes I do know that. But doctors are currently being advised not to do that with this drug. Or at least patients are being advised not to do it. Latest study, while not perfect, does indicate that it is ineffective, and possibly harmful.

Again, my point in all of this is the lack of transparency. I am no kind of doctor so I do not claim to know who is right and who is wrong. But I have to make the decisions, so a lack of transparency becomes a serious hindrance to belief.

Oh, your closing remark fits perfectly with the rest of the post.
 

·
Premium Member
Joined
·
471 Posts
"There could be lifetime immunity from Covid19 if people generate IgG antibodies, kinda like chickenpox, smallpox, polio, etc., so her statement about lifetime immunity is not out of bounds." Isn't it amazing how much difference one word can make? Could: used to indicate possibility. Unfortunately she didn't use the word could, which made her statement seriously out of bounds.

Oh, yes I do know that. But doctors are currently being advised not to do that with this drug. Or at least patients are being advised not to do it. Latest study, while not perfect, does indicate that it is ineffective, and possibly harmful.

Again, my point in all of this is the lack of transparency. I am no kind of doctor so I do not claim to know who is right and who is wrong. But I have to make the decisions, so a lack of transparency becomes a serious hindrance to belief.

Oh, your closing remark fits perfectly with the rest of the post.
Do you occasionally use aspirin or Tylenol?
 

·
Registered
Joined
·
197 Posts
Do you occasionally use aspirin or Tylenol?
Yes I do. But we were talking about Dr. Cahill and her speech, not me, or my medical history. Not sure why my using aspirin or Tylenol has any bearing on the veracity of my claiming she is a politician, and unscientific in her claim of lifetime immunity from COVID=19.

Or my claim that the use of hydroxychloroquine for the treatment/prevention of COVID-19 outside the hospital or clinical trials is being actively discouraged by the majority of the medical profession. We are discussing your opinion vs FDA, CDC, and others. I am giving their opinion, with which I agree. Since I am not a doctor, if the medial profession overall changes their opinion, I'll change mine. In medicine I am a follower, not a leader.
 

·
Premium Member
Joined
·
471 Posts
Yes I do. But we were talking about Dr. Cahill and her speech, not me, or my medical history. Not sure why my using aspirin or Tylenol has any bearing on the veracity of my claiming she is a politician, and unscientific in her claim of lifetime immunity from COVID=19.

Or my claim that the use of hydroxychloroquine for the treatment/prevention of COVID-19 outside the hospital or clinical trials is being actively discouraged by the majority of the medical profession. We are discussing your opinion vs FDA, CDC, and others. I am giving their opinion, with which I agree. Since I am not a doctor, if the medial profession overall changes their opinion, I'll change mine. In medicine I am a follower, not a leader.
Wrong again goofball. The FDA has allowed hydroxychloro for emergency use as we’ve discussed over and over again. Look goofball the clinical use of hydroxychloro is not my clinical opinion but the clinical opinion of many physicians in the trenches who have used it for decades and are using it daily with active Covid infections. Are we clear? Dr. Cahill could be correct that people who are infected may have lifetime immunity if they develop IgG ab, so your argument that she is unscientific is without merit.

Do you know that aspirin is rated the 44th most dangerous drug out of the list of the top 50 most dangerous medications? Do you know that acetaminophen (Tylenol) is rated the 39th most dangerous drug out of the list of the top 50 most dangerous medications? Do you know that hydroxychloroquine (Plaquenil) is not on the list of the top 50 most dangerous medications? If you talked to a transplant nurse friend she’d tell you horror stories of many kidney failures from Tylenol use. Yet you take it at times. Are we clear yet? Yes you are a goofball follower. That is clear. I’m done with you now as like most fancy dandy boy liberals you’re a waste of my time.
 

·
Registered
Joined
·
803 Posts

·
Registered
Joined
·
197 Posts
Wrong again goofball. The FDA has allowed hydroxychloro for emergency use as we’ve discussed over and over again. Look goofball the clinical use of hydroxychloro is not my clinical opinion but the clinical opinion of many physicians in the trenches who have used it for decades and are using it daily with active Covid infections. Are we clear? Dr. Cahill could be correct that people who are infected may have lifetime immunity if they develop IgG ab, so your argument that she is unscientific is without merit.

Do you know that aspirin is rated the 44th most dangerous drug out of the list of the top 50 most dangerous medications? Do you know that acetaminophen (Tylenol) is rated the 39th most dangerous drug out of the list of the top 50 most dangerous medications? Do you know that hydroxychloroquine (Plaquenil) is not on the list of the top 50 most dangerous medications? If you talked to a transplant nurse friend she’d tell you horror stories of many kidney failures from Tylenol use. Yet you take it at times. Are we clear yet? Yes you are a goofball follower. That is clear. I’m done with you now as like most fancy dandy boy liberals you’re a waste of my time.
Nope, did not know any of that, and did not care. Not my job. That's what I pay doctors for.

And Dr. Cahill could be correct if she had said if, but she didn't. So her statement was misleading and political, as well as dangerous.

And if there are many physicians in the trenches who are using hydroxychloro for the treatment of COVID infections, maybe you can explain this conclusion from a recent study:

We were unable to confirm a benefit of hydroxychloroquine or chloroquine, when used alone or with a macrolide, on in-hospital outcomes for COVID-19. Each of these drug regimens was associated with decreased in-hospital survival and an increased frequency of ventricular arrhythmias when used for treatment of COVID-19.

And if Tylenol is so dangerous, perhaps it should not be given to patients when there is no confirmed benefit to its use. Maybe it should be limited to only those issues where there is a recognized benefit.

Again, your name calling is another example incorrect conclusions drawn from insufficient data. And I can understand were discussing differing views and answering difficult questions would be a waste of time for some.
 

·
Premium Member
Joined
·
471 Posts
I finally decide to bring in my star football player in the last quarter of a game that we’re seriously getting beat, 37 to 3. Time is running out, and there is not enough time to recoup my losses although I bring in my star player, and we lose. I incorrectly conclude my star player is not a star player and he’s not very good after all. In reality if I would have played my star player from the beginning of the game the outcome probably would have been different. Many of the studies using hydroxychloroquine are setting it up for failure using it on seriously ill hospitalized patients with end stage disease from the infection then claiming it’s not effective when those patients die. Infectious disease docs will tell you: infection 101, bring your best army in immediately at the start of infection, don’t wait. These docs are using hydroxychloro right away, before a patient becomes so ill they end up in the hospital. Those are the success cases. That’s the difference when designing a clinical trial.
 
621 - 640 of 651 Posts
Top